The Effect of Biomarkers of Inflammation on Graft Function in Kidney Transplantation

The Effect of Biomarkers of Inflammation on Graft Function

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05753488

Enrollment

100

Registered

2023-03-03

Start date

2023-03-31

Completion date

2023-10-31

Last updated

2023-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Renal Transplant Failure and Rejection

Brief summary

The aim of the study was to investigate the relationship of inflammation markers with postoperative graft function and mortality in patients undergoing kidney transplantation.

Interventions

DIAGNOSTIC_TESTgraft function

renal transplantation

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

12 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* patients underwent renal transplantation

Exclusion criteria

* patient refusal

Design outcomes

Primary

Measure	Time frame	Description
RDW	baseline	Red Cell Distribution Width
PNI	baseline	prognostic nutrition index (PNI) calculated as 10 × serum albumin (g/dl) + 0.005 × total lymphocyte count (per mm3)
De Ritis	baseline	De Ritis described the ratio between the serum levels of aspartate transaminase (AST) and alanine transaminase (ALT)
graft function	through study completion, an average of 1 year	—

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026